SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCompre Grp.28 Regulatory News (RG62)

Share Price Information for Compre Grp.28 (RG62)

Share Price is delayed by 15 minutes
Get Live Data
0.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: -
RG62 Live PriceLast checked at - London Stock Exchange

Intraday Compre Grp.28 Share Chart

Compre announces second deal with SiriusPoint

2 Mar 2023 13:32

RNS Number : 7126R
Compre Group Holdings Limited
02 March 2023
 

 

Press release

2nd March 2023

 

Compre announces second deal with SiriusPoint

 

SiriusPoint Ltd. ("SiriusPoint"), NYSE-listed (SPNT) global underwriter, and Compre Group Holdings Limited ("Compre"), the Bermuda headquartered international legacy group, today announce that they have signed an agreement for a ground-up Loss Portfolio Transfer ("LPT") on a diversified portfolio of primarily reinsurance business. The transaction's inception is subject to regulatory approvals and other conditions of closing.

 

The LPT covers approximately $1.3bn of reserves, underwritten by SiriusPoint's international reinsurance business headquartered in Sweden, and its Lloyd's Syndicate 1945. The portfolio comprises several classes of business from 2021 and prior underwriting years, with SiriusPoint retaining claims handling authority on ongoing business. The announcement follows a comprehensive re-underwriting of SiriusPoint's reinsurance portfolio, and the restructuring of the Company's underwriting platform.

 

The LPT will be underwritten by Compre's class 3B Bermudian reinsurer, Pallas Reinsurance Company Ltd. ("Pallas Re").

 

Scott Egan, SiriusPoint Chief Executive Officer, said: "This is a transformational deal for SiriusPoint. It demonstrates decisive and continuing execution against our strategic priorities of simplifying our business, reducing future volatility, and improving the profitability of our Company. By transferring these reserves, we are aligning our balance sheet to our go-forward strategy. The expected substantial capital release should further increase our balance sheet strength, and the reserve redundancy of approximately $100m validates our reserving policy while being accretive to returns. As stated at our recent earnings update, we feel confident about our prospects in 2023, with this deal providing another evidence point of our progress. I am pleased we are partnering with Compre once again, continuing a valued relationship with a transaction that supports us in realising SiriusPoint's full potential."

 

Compre CEO Will Bridger said: "Today's announcement represents another important milestone in Compre's evolution, and we are delighted to further assist SiriusPoint with the strategic repositioning of its reinsurance business. This transaction continues a valuable relationship, providing both significant diversification and growth to our balance sheet and enabling SiriusPoint to meet its strategic goals. As one of the largest transactions underwritten in the legacy market, it also demonstrates that Compre's client-focussed approach is recognised across the insurance and reinsurance industry for providing finality solutions on transactions of increasing significance."

SiriusPoint was advised on this transaction by AJ Gallagher & Co. and Mayer Brown LLP.

 

Compre was advised by Debevoise & Plimpton LLP and EY.

 

- Ends -

Notes to Editors:

SiriusPoint is a global underwriter of insurance and reinsurance providing solutions to clients and brokers around the world. Bermuda-headquartered with offices in New York, London, Stockholm and other locations, we are listed on the New York Stock Exchange (SPNT). We have licenses to write Property & Casualty and Accident & Health insurance and reinsurance globally. Our offering and distribution capabilities are strengthened by a portfolio of strategic partnerships with Managing General Agents within our Insurance & Services segment. With $2.9 billion total capital, SiriusPoint's operating companies have a financial strength rating of A- (Excellent) from AM Best, S&P and Fitch. For more information, please visit www.siriuspt.com

 

Compre is a leading legacy specialist with over 30 years of experience in the acquisition and management of discontinued and legacy non-life insurance and reinsurance business. Compre has experience of acquiring most classes of direct and reinsurance business, including general liability, marine and motor liability, and US APH. Compre has operations in Bermuda, Finland, Germany, Malta, Switzerland, the UK and at Lloyd's. www.compre-group.com 

 

Contacts

 

SiriusPoint Investor Relations

Dhruv Gahlaut, 

dhruv.gahlaut@siriuspt.com

+44 7514 659 918

 

SiriusPoint Media

Sarah Hills, 

Rein4ce sarah.hills@rein4ce.co.uk+44 7718882011

 

Compre Media

David Haggie / Richard Adams / Shipra Khanna, Haggie Partners

+44 20 7562 4444

 

 

Forward-Looking StatementsWe make statements in this report that are forward-looking statements within the meaning of the U.S. federal securities laws. We intend these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements in the U.S. Federal securities laws. These statements involve risks and uncertainties that could cause actual results to differ materially from those contained in forward-looking statements made on behalf of SiriusPoint. SiriusPoint is also subject to risks and uncertainties in connection with its ordinary course business, including the impact of general economic conditions and conditions affecting the insurance and reinsurance industry, the adequacy of our reserves, fluctuation in the results of operations; pandemic or other catastrophic event, such as the ongoing COVID-19 outbreak; uncertainty of success in investing in early-stage companies, such as the risk of loss of an initial investment, highly variable returns on investments, delay in receiving return on investment and difficulty in liquidating the investment; the costs, expense and difficulties of the integration of the operations of Third Point Reinsurance Ltd. and Sirius International Insurance Group, Ltd.; our ability to assess underwriting risk, trends in rates for property and casualty insurance and reinsurance, competition, investment market and investment income fluctuations, trends in insured and paid losses, regulatory and legal uncertainties and other risk factors described in SiriusPoint's Annual Report on Form 10-K for the period ended December 31, 2022. Except as required by applicable law or regulation, we disclaim any obligation to publicly update or revise any forward-looking statement to reflect changes in underlying assumptions or factors, or new information, data or methods, future events or other circumstances after the date of this report.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CIRFLFVVVIIFIIV
Date   Source Headline
8th Jun 20263:16 pmRNSSenior Management Change
14th Apr 20269:02 amRNSCompre announces FY 2025 results
6th Feb 202612:11 pmRNSCompre Appoints David Atkins as Deputy CEO
12th Nov 20258:00 amRNSSenior Management Change
30th Sep 20257:56 amRNSInterim Financial Report - 30 June 2025
14th May 202511:17 amRNSCompre completes portfolio transfer from Ethias
17th Apr 20257:56 amRNSCompre announces FY 2024 results
16th Apr 20259:00 amRNSCompre acquires Covéa US subsidiary
13th Mar 20252:10 pmRNSCompre appoints John Howard as chairman
7th Feb 20255:00 pmRNSBoard and Senior management changes
12th Sep 20248:00 amRNSInterim Financial Report - 30 June 2024
22nd Aug 20245:19 pmRNSCompre and Accelerant execute legacy transaction
15th Aug 20247:00 amRNSCompre announces change of registered address
3rd Jun 20247:00 amRNSCompre reports record results in ‘landmark’ year
10th Jan 20249:00 amRNSCompre acquires two European liability portfolios
30th Nov 20234:37 pmRNSCompre appoints two new members to Group Board
11th Oct 20232:12 pmRNSInterim Financial Report - 30 June 2023
10th Oct 20234:55 pmRNSInterim Financial Report - 30 June 2023
4th Sep 20239:00 amRNSCompre completes acquisition of Covéa subsidiary
3rd Jul 20231:15 pmRNSSiriusPoint and Compre complete LPT transaction
22nd May 20237:40 amRNSCompre acquires workers’ comp portfolio from SUNZ
12th May 20231:45 pmRNSAudited Annual Financial Report - 31 December 2022
2nd Mar 20231:32 pmRNSCompre announces second deal with SiriusPoint
20th Oct 20227:00 amRNSCompre agrees to acquire subsidiary from Covéa
25th Aug 20228:22 amRNSCompre acquires further MedMal portfolio
15th Aug 20227:00 amRNSCompre acquires German liability portfolio

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.